There’s been a lot of press floating around lately about the push to develop a framework for biogeneric (or biosimilar, […]

I’ve been invited to join the editorial board of the nascent Open Biotechnology Journal. The Open Biotechnology Journal is a

Scientific Advances The MaRS Blog has a captivating story of Canada’s recent major diabetes discovery. The first discovery, in 1920,

This edition of the Carnival of Biotechnology features a number of posts on distressing industry trends, some enlightening patent discussion,

Harvard’s Gary Pisano has recently published a book titled “Science Business: The Promise, the Reality, and the Future of Biotech“

Lots of interesting developments since the last edition: Pfizer’s high-profile drug failiure, a new law against violent extremists, good news

Intellectual Property and Lawsuits Culture Dish has a post on a DNA sequencing technique patent dispute — Enzo biochem claims

This edition of the Carnival of Biotechnology features some interesting commentary on issues ethics, how to dress for drug ads,

This edition of the Carnival of Biotechnology features commentary on regulatory problems and progress, international development, and failed commercialization strategies.